Appointment booking for Dr. Girindra Raval, MD is currently not available.Dr. Girindra Raval, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Girindra Raval, MD (he/him) is a Oncologist, Internist in Augusta, GA with over 17 years of experience. What is your opinion of Dr. Girindra Raval, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Girindra Raval, MD has received over $1,843 which includes payments from the following companies:
$210.89 from Medtronic Vascular, Inc.
$165.67 from Medtronic USA, Inc.
$140.15 from Fisher & Paykel Healthcare Inc
$131.33 from AstraZeneca Pharmaceuticals LP
$128.02 from Abbott Laboratories
$125.00 from Genentech USA, Inc.
$121.59 from E.R. Squibb & Sons, L.L.C.
$119.92 from Janssen Pharmaceuticals, Inc
$117.49 from Eisai Inc.
$114.98 from Amgen Inc.
$98.14 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$97.34 from Medtronic Sofamor Danek USA, Inc.
$93.99 from Kite Pharma, Inc.
$55.00 from Incyte Corporation
$50.36 from Novo Nordisk Inc
$23.17 from Valeant Pharmaceuticals North America LLC
$22.85 from The Medicines Company
$15.38 from Merck Sharp & Dohme Corporation
$12.44 from Pfizer Inc.
Payments received by Dr. Girindra Raval, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!